The 3' untranslated region of human p53 mRNA represses translation both in vitro and in vivo. Here, we identify a cis-acting 66-nucleotide U-rich sequence in the human p53 mRNA 3' untranslated region that mediates translational repression. Using UV crosslinking, we detect a 40 kDa protein that interacts speci®cally with the p53 3'UTR containing the repressor element. Enhanced translation of p53 mRNA contributes to the accumulation of p53 protein in cells exposed to gradiation and could be a consequence of relieving the inhibition mediated by the repressor element.
Introduction
The p53 tumor suppressor protein plays a critical role in the cellular response to DNA damage leading to cell cycle arrest in G1 or apoptosis depending on cell type or culture conditions (Clarke et al., 1993; Kastan et al., 1991; Kuerbitz et al., 1992; Lowe et al., 1993a,b) . Although p53 mRNA is ubiquitously expressed in mammalian cells, p53 protein levels are usually low or undetectable in normal cells owing to the protein's short half-life (Oren et al., 1981; Rogel et al., 1985) and slow rate of synthesis (Fu et al., 1996; Mosner et al., 1995) . DNA strand breaks produced by g-irradiation or by DNA repair intermediates following treatment with UV-radiation or chemotherapeutic agents result in the accumulation of p53 protein and in the activation of its transcriptional activity (Fritsche et al., 1993; Kastan et al., 1991; Lu and Lane, 1993) . The rapid and transient up-regulation of p53 protein is mediated primarily through a post-transcriptional mechanism involving increased p53 mRNA translation (Fu and Benchimol, 1997; Mosner et al., 1995) and increased p53 protein stability (Maltzman and Czyzyk, 1984) . The rate of p53 protein synthesis was shown to increase in UV-treated cells as assessed by the incorporation of [ 35 S]methionine during a 30-min metabolic labelling assay (Maltzman and Czyzyk, 1984) . Moreover, the ability of protein synthesis inhibitors to block the increase in p53 protein after DNA damage is consistent with translation playing a role in this process (Fritsche et al., 1993; Kastan et al., 1991; Tishler et al., 1993) . While elevated levels of p53 protein are believed to be important to initiate the events that lead to G1 arrest or apoptosis after DNA damage, there is compelling evidence that posttranslational modi®cation of p53 protein is also required to activate the latent sequence-speci®c DNA binding and transactivation functions of p53 (reviewed in Giaccia and Kastan, 1998) . The complexity of the mechanism(s) governing p53 protein accumulation in response to DNA damage is underscored by the ®ndings that the kinetics and duration of p53 protein accumulation dier in dierent cells and in response to dierent DNA damaging agents (Lu and Lane, 1993) . Moreover, distinct pathways appear to be activated in UV-and g-irradiated cells to elevate p53 protein levels (Maki and Howley, 1997) . The relative importance of increased p53 mRNA translation and increased p53 protein stability is likely to vary in dierent cell types and in response to dierent DNA damaging agents.
We reported previously that human p53 mRNA was more actively translated in g-irradiated cells and that a region in the distal end of the 3'UTR of human p53 mRNA was capable of repressing translation of a chimeric reporter RNA both in vitro (Fu et al., 1996) and in vivo (Fu and Benchimol, 1997) . Moreover, chimeric transcripts bearing the distal end of the p53 3'UTR were translationally activated in cells exposed to g-radiation (Fu and Benchimol, 1997) . In this study, the translational repressor element in the p53 3'UTR was mapped and found to reside within a 66 nt U-rich sequence at the 5' boundary of an Alu-like element. Using UV cross-linking assays, we have detected a 40 kDa protein that interacts speci®cally with the p53 mRNA 3'UTR containing the repressor element.
Results
A 66 nt U-rich sequence within the human p53 3'UTR mediates translational repression To identify the nucleotide sequence element present on the distal end of the p53 3'UTR that mediates translational repression, a series of chimeric luciferase reporter constructs bearing dierent regions of the human p53 3'UTR was constructed, and the translational eciency of the resulting transcripts was determined in stably transfected MCF-7 clones. The constructs are depicted in Figure 1a . Brie¯y, DA constructs contain a deletion of the entire Alu-like element (nt 715 ± 1068), DU constructs contain a deletion of the U-rich sequence present at the 5' end of the Alu-like element (nt 716 ± 782), DXH constructs contain a deletion of the distal end of the Alu-like element but retain the U-rich region (nt 862 ± 1068); constructs with a 5' pre®x contain the entire p53 5'UTR joined to the 5' end of the luciferase coding region. MCF-7 cells were electroporated with linearized plasmid DNA and stable transfectants were selected for growth in G418. The levels of chimeric luciferase RNA and luciferase activity present in each of the clones were determined, and the ratio of luciferase activity/luciferase RNA was used to estimate the translational eciency of the various chimeric transcripts. Twenty-three MCF-7 clones, selected solely on the basis of having detectable luciferase RNA, were analysed in this manner (Table 1) . Consistent with our previous ®ndings, the chimeric transcripts bearing the distal portion of the human p53 3'UTR were translated less eciently than transcripts lacking this region. Importantly, deletion of a 66 nt U-rich fragment abolished translational repression mediated by the p53 3'UTR. The MCF-7 clones can be classi®ed into two distinct groups on the basis of normalized luciferase activity (Figure 2) . All of the clones in group A with high luciferase activity express chimeric luciferase transcripts that lack the U-rich sequence in their 3'UTRs (DU) whereas all the clones in group B with low luciferase activity express chimeric transcripts that contain the U-rich sequence (+U). For a number of the clones, we have measured luciferase protein levels by Western blotting (data not shown) and have con®rmed that the luciferase activity measurements re¯ect luciferase protein levels. On the basis of this complete concordance, we conclude that the 66 nt Urich sequence (nt 716 ± 782) plays an essential role in translational repression of chimeric luciferase RNAs in MCF-7 cells and we infer that this same element is involved in translational repression of endogenous p53 mRNA. The inclusion of the p53 5'UTR at the 5' end of the chimeric transcripts had no apparent eect on their expression. Although no eect was detected within the context of chimeric transcripts, we cannot exclude an involvement of the 5'UTR on translational control of native p53 transcripts.
In comparison with the human p53 3'UTR, the mouse p53 3'UTR is much shorter and lacks overall sequence similarity; however, it does contain a U-rich polypyrimidine tract close to the polyadenylation signal (Matlashewski et al., 1984; Pennica et al., 1984) . The 66 nt repressor element in the human p53 3'UTR is shown in Figure 1b alongside the conserved U-rich sequence present in the mouse p53 3'UTR. Notably, the human and mouse RNA sequences contain an uninterrupted polypyrimidine tract of 38 and 23 residues, respectively. The human sequence contains Figure 1 Reporter constructs expressing chimeric luciferase-p53 UTR transcripts used in this study. (a) All constructs contain the ®re¯y luciferase coding sequence as a reporter gene but are dierent in their 5' or 3' untranslated regions: pRLucRU contains the entire human p53 3'UTR following the luciferase coding sequence; pRLucRUDA contains a deletion of the Alu-like element in the p53 3'UTR; pRLucRUDU contains an internal 66-nucleotide deletion in the p53 3'UTR; pRLucRUDXH plasmid contains a deletion of most of the Alu-like element in the p53 3'UTR but leaves the U-rich 66-nucleotide segment intact; pRLucA contains the distal end of the human p53 3'UTR; pRLucADU contains the distal region of p53 3'UTR with an internal deletion of the U-rich sequence; pRLucADXH contains the distal region of p53 3'UTR with an internal deletion of most of the Alu-like element; constructs with a 5' pre®x contain the entire p53 5'UTR joined to the 5' end of the luciferase coding region. Transcription of the chimeric luciferase cDNAs was controlled by the RSV long terminal repeat and the polyadenylation signal (pA) was derived from the bovine growth hormone (BGH) gene. Numbering starts at the ®rst nucleotide of the TGA termination codon and proceeds to the last nucleotide preceding the poly(A) tail. (b) The 66-nucleotide sequence deleted in the DU constructs is shown together with the conserved polypyrimidine tract in the mouse p53 3'UTR (nucleotides 1528 ± 1589; Pennica et al., 1984) an uninterrupted stretch of 17 uridylic acid residues while the mouse sequence contains 15 consecutive uridylic acid residues. We also ®nd that the U-rich repressor element contains a motif, UCUUUU, that is conserved in the p53 mRNA 3'UTR of mouse and other species. It will be important to determine if this conserved U-rich element in mouse p53 mRNA also mediates translational repression.
Cellular proteins that bind to the p53 mRNA 3'UTR containing the 66 nt repressor element
The 66 nt element may represent a binding site for proteins that regulate p53 mRNA translation. To identify factors that can interact with this site, we prepared cell extracts from MCF-7 cells. These cells contain wild-type p53 alleles and exhibit elevated levels of p53 protein after g-irradiation (Fu and Benchimol, 1997) . Extracts prepared from these cells were used in UV cross-linking assays with 32 P-labelled probes from the p53 3'UTR. One RNA probe encompassed nucleotides 489 to 1184 of the p53 3'UTR ( Figure 1 ) and is referred to as 3'UTR; the second probe contained an internal 66 nt deletion of the U-rich repressor element and is referred to as 3'UTRDU. Protein and RNA mixtures were incubated for 10 min at 308C prior to UV irradiation, RNase digestion and resolution by denaturing polyacrylamide gel electrophoresis. Three proteins with apparent molecular masses of 66 kDa, 62 kDa, and 40 kDa were crosslinked preferentially to the 3'UTR probe (Figure 3a) . The two probes used in the UV cross-linking assays each contained 30 adenine residues (A 30 ) at the 3' end. Similar results were obtained when the UV crosslinking experiments were repeated with RNA probes containing 100 adenine residues (A 100 ) (Figure 3b ) or with poly(A)
7 RNA probes (data not shown). RNA data is the result of quantitation of Northern blots using a Molecular Dynamics phosphorImager. All values were normalized to GAPDH RNA to ensure equivalent loading of RNA on the blots. The ratio of the luciferase RNA signal to the GAPDH RNA signal in ADU2 cells was arbitrarily set to 1.0. Luciferase activity (relative light units per mg protein) represents the mean level derived from at least three independent experiments. The ratio of luciferase activity/luciferase mRNA provides a measure of translational eciency Figure 2 The U-rich sequence in the human p53 mRNA 3'UTR reduces translational eciency. The chimeric luciferase RNA level and the luciferase activity present in each of the MCF-7 clones was determined by Northern blot analysis and luciferase enzymatic assay respectively. The ratio of luciferase activity/ luciferase mRNA provides a measure of translational eciency. On the basis of these values, the MCF-7 clones can be placed into one of two groups. Group A clones have high values of luciferase activity (after correction for dierences in chimeric luciferase mRNA abundance) and all of the clones in this group express chimeric luciferase transcripts in which the U-rich sequence in the p53 3'UTR is missing (DU transcripts). Group B clones have lower levels of normalized luciferase activity and all of the clones in this group express chimeric luciferase transcripts containing the U-rich sequence (+U transcripts). The histogram represents the mean values of the normalized luciferase activity obtained from three to six independent experiments for each clone. The error bars represent the standard error of the mean. The clones are described in Table 1 To assess the speci®city of the cross-linking reaction, the 32 P-labelled 3'UTR/A 100 probe was incubated with the MCF-7 extract in the presence of molar excess unlabelled competitor RNA either 3'UTR/A 100 or 3'UTRDU/A 100 . Addition of excess unlabelled 3'UTR/A 100 transcripts eciently competed with the labelled probe for binding to the 40 kDa protein (Figure 3b ). In contrast, addition of increasing amounts of unlabelled 3'UTRDU/A 100 RNA did not interfere eciently with binding to the 40 kDa protein (Figure 3b ). Binding to the 66 kDa and 62 kDa proteins was not diminished by the addition of excess unlabelled self competitor RNA (Figure 3b) . We conclude that the 40 kDa protein binds speci®cally to the p53 3'UTR containing the 66 nt repressor element. Further experiments are required to assess the binding speci®city of the 66 kDa and 62 kDa proteins to the p53 3'UTR. Speci®c binding of a 40 kDa protein to p53 3'UTR probes containing the repressor element but not to 3'UTRDU probes was also observed in UV cross-linking studies with extracts prepared from the human acute leukemia cell line, OCI/AML-3 (data not shown).
Discussion
Previously, we identi®ed a region in the distal end of the 3'UTR of human p53 mRNA that was capable of repressing translation of p53 RNA and chimeric reporter RNA in vitro (Fu et al., 1996) as well as in vivo (Fu and Benchimol, 1997) . In this study, a series of stable clones was generated after transfection of MCF-7 cells with expression plasmids containing luciferase cDNA fused to various portions of the p53 3'UTR. Measurement of luciferase activity and chimeric luciferase RNA levels in these clones allowed us to map the repressor element to a 66 nt U-rich region of the p53 mRNA 3'UTR. All chimeric luciferase-p53 3'UTR transcripts bearing the repressor element showed decreased levels of luciferase activity and protein compared with chimeric transcripts in which the U-rich sequence was deleted from the p53 3'UTR.
Previously, we provided direct in vivo evidence for enhanced translation of p53 mRNA in response to girradiation by showing increased association of p53 mRNA with polysomes (Fu and Benchimol, 1997) . In addition, we demonstrated that chimeric luciferase-p53 3'UTR transcripts containing the repressor element expressed more luciferase protein and luciferase enzymatic activity after g-irradiation, whereas chimeric luciferase-p53 3'UTR transcripts missing the translational control element did not show a radiationdependent increase in luciferase expression (Fu and Benchimol, 1997) . We inferred from these studies that translational repression mediated by the repressor element is relieved by g-irradiation. Whether enhanced translation of p53 mRNA in irradiated cells occurs by elimination of the repression mechanism alone or requires additional activation events is not known.
Models to explain translational regulation of p53 mRNA must address how the repressor element mediates repression and how DNA damage caused by g-radiation relieves this repression. Repression and activation of p53 mRNA translation may be controlled through RNA-protein interactions at or near the Urich repressor element. Such trans-acting factors may interact directly with the translational machinery. Alternatively, the U-rich repressor element could interact with the poly(A) tail and interfere with the recruitment of factors required for the initiation of translation. The interaction may be direct involving heteroduplex formation between the U-rich element and the poly(A) tail of p53 mRNA or indirect involving RNA binding proteins that recognize the p53 3'UTR and facilitate association with the poly(A) tail. Translation of p53 mRNA may be activated by trans-acting factors that bind to the 3'UTR resulting in dissociation of the A : U heteroduplex and unmasking of the poly(A) tail. The 40 kDa protein that binds speci®cally to the p53 mRNA 3'UTR containing the 66 nt repressor element represents a candidate for a translational regulatory factor.
Translational control elements may function solely as RNA, forming structures that inhibit translation, or through the activity of trans-acting factors that bind to these elements. Elements that appear to regulate translation have been discovered in the 3'UTRs of numerous mRNAs (reviewed in Jackson and Standart and Jackson, 1994 ; Wickens et al., Binding of cellular proteins to the labelled 3'UTR probe was performed in the presence of unlabelled competitor RNA as indicated. Competitor RNAs were added to the reaction mixtures and incubated for 10 min at 308C prior to the addition of the labelled probes. The labelled 3'UTR probe contains 100 adenine residues at the 3' end (3'UTR/A 100 ). The competitor RNAs also contain 100 adenine residues at their 3' ends. The arrowheads point to the same proteins as in (a) 1997). A number of translational control elements in 3'UTRs have been shown to contain U-rich sequences and, for some of these, the interacting proteins have been identi®ed. It is evident, however, that regulatory elements utilize various dierent mechanisms to exert their eect on translation including control of poly(A) tail elongation (Hake and Richter, 1994) , and recruitment of translational repressor proteins (Bashaw and Baker, 1997; Murata and Wharton, 1995; Ostareck et al., 1997) . The U-rich sequence present in the 3'UTR of human p53 mRNA is not identical with any of the other U-rich translational control elements that have been identi®ed. It is likely that translational regulation of p53 mRNA is complex involving multiple protein-protein and protein-RNA interactions. In conclusion, the present study reveals a novel facet in the complex regulation of p53 gene expression.
Materials and methods

Plasmids
The plasmid pRLucRU was described previously (Fu and Benchimol, 1997) . pRLucRUDU was derived from pRLucRU by deletion of a 66 nt U-rich sequence in the p53 3'UTR (+716 to +782, Figure 1 ) using PCR-based mutagenesis. The distal region of the p53 3'UTR in pRLucRU was ampli®ed in a PCR reaction using a 5' sense primer complementary to the¯anking ends of the desired deletion (5'AATTGGATCCG AGACTGGGTCTC3') and a 3' antisense primer, AS-4, complementary to the end of the p53 3'UTR (Fu et al., 1996) . The BamHI/HincII fragment of the resulting PCR product was then exchanged with the BamHI/ HincII fragment from pRLucRU. pRLucRUDXH was generated by deletion of the XhoI/HincII fragment in the p53 3'UTR (+858 to +1066, Figure 1 ) from pRLucRU and blunt-end ligation of the ®lled ends. To generate 5'pRLucRU and 5'pRLucRUDU, the 5' end of the ®re¯y luciferase gene was ®rst modi®ed in a PCR reaction to generate a NcoI site at the AUG codon, using luciferase speci®c primers 5'luc (sense: 5'-TTATAAGCTTCCATGGAACGCCAAAAAC-3', the NcoI site is underlined) and 5'antiluc (antisense: 5'-GGGCGTATCTCTTC-3'). The HindIII/XbaI fragment of the resulting luciferase fragment was then exchanged with the HindIII/XbaI fragment from pRLucRU and pRLucRUDU. The full-length p53 5'UTR sequence was obtained from the pR4-2 plasmid (Harlow et al., 1985) after digestion with XbaI and NcoI and inserted between the KpnI and NcoI sites in the modi®ed pRLucRU and pRLucRUDU plasmids. The resulting 5'pRLucRU and 5'pRLucRUDU plasmids contain a full-length p53 5'UTR immediately downstream of the RSV promoter. All other plasmids listed in Figure 1 were derived using similar strategies. pRLucA is the same as pRLucAlu (Fu and Benchimol, 1997) . All constructs were con®rmed by DNA sequencing.
DNA transfection and establishment of stably transfected cell lines
DNA transfection was carried out as described (Fu and Benchimol, 1997) . Brie¯y, plasmids encoding chimeric luciferase-p53 3'UTR transcripts were linearized at the ScaI site. Subcon¯uent cultures of MCF-7 cells were trypsinized and resuspended in ice-cold a-MEM containing 10 mg of linearized plasmid DNA. The cells were kept on ice for 10 min prior to electroporation using a Bio-Rad electroporator at 250 V and 960 mF. After electroporation, the cells were kept on ice for a further 10 min, resuspended in a-MEM containing 10% FCS and incubated at 378C. Two days after electroporation, the culture medium was replaced with fresh medium containing 0.4 mg/ml of G418 (Geneticin, Gibco). After 4 weeks of selection, the G418-resistant colonies were picked and grown in a-MEM containing 10% FCS and 0.2 mg/ml of G418.
Northern blot analysis
Total RNA was isolated from MCF-7 derived clones using the guanidinium thiocyanate method (Chirgwin et al., 1979) . The RNA was separated by electrophoresis on a 1% agarose gel containing 6% formaldehyde, transferred onto a nitrocellulose membrane and hybridized with 32 P-labelled cDNA probes for human p53 (Harlow et al., 1985) or ®re¯y luciferase (de Wet et al., 1987) . The membranes were stripped and reprobed with 32 P-labelled human ribosomal protein L35 (Herzog et al., 1990) or rat GAPDH cDNA (Fort et al., 1985) . The blots were exposed to X-ray ®lm for autoradiography. RNA levels were determined with a Molecular Dynamics PhosphorImager using multiquant software.
Luciferase assay
Luciferase activity in transfected MCF-7 clones was determined following the protocol recommended by the supplier of the Luciferase Assay System (Promega). Brie¯y, subcon¯uent cultures of clonal MCF-7 cells were lysed in their culture dishes with 250 ml of Cell Culture Lysis Reagent (Promega). Lysates were collected, transferred to centrifuge tubes and spun brie¯y to remove debris. The protein concentration in each sample was determined as described by Bradford (1976) . Luciferase activity was measured in triplicate on a LB9507 luminometer (Fisher Scienti®c Limited) using 5 mg of protein extract. The intensity of light emission was assayed by integration over a 5 s interval after the injection of 5.3 mM ATP and 4.7 mM luciferin.
In vitro transcription
A 695 nt XbaI/EcoRI fragment of the p53 3'UTR (nt 489 ± 1184) was removed from p2516 (Fu et al., 1996) and cloned into pGEM-4 to generate plasmid 3'UTR, and into pSP64poly(A) (Promega) to generate the 3'UTR/A 30 plasmid which contains a dA/dT tract of 30 residues after the p53 3'UTR sequence. The 3'UTR/A 100 plasmid was generated by exchanging the dA/dT 30 tract in the 3'UTR/A 30 plasmid with the dA/dT 100 tract from pSP65AT (Baum et al., 1988) . The 3'UTRDU, 3'UTRDU/A 30 and 3'UTRDU/A 100 plasmids were generated by replacing the XbaI/XhoI fragments in plasmids 3'UTR, 3'UTR/A 30 , and 3'UTR/A 100 with the XbaI/XhoI fragment from pRLucRUDU (Figure 1a) , respectively. Transcripts were prepared with T7 or SP6 RNA polymerase (Melton et al., 1984) . Labelled transcripts were prepared using [a-32 P]UTP (DuPont) at 50 mCi/20 ml supplemented with 1 mM each of ATP, GTP and CTP. The reactions were incubated at 378C for 60 min. The RNA probes were extracted with phenol/chloroform and precipitated with ethanol.
UV cross-linking assay
Cells were washed with cold PBS buer, resuspended in a buer containing 10 mM HEPES, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT and 1 mM PMSF, and incubated at 48C for 10 min. Cells were lysed using a Dounce homogenizer and the nuclei were removed by centrifugation at 2000 r.p.m. for 15 min. The supernatants were mixed with 0.11 volume of a buer containing 0.3 M HEPES, pH 7.9, 1.4 M KCl, and 0.03 M MgCl 2 , and centrifuged at 100 000 g for 60 min. After centrifugation, the supernatants were collected and glycerol was added to a ®nal volume of 20%.
The lysates were stored at 7708C. UV cross-linking was performed in a total volume of 10 ml containing 30 mM HEPES, 0.5 mM DTT, 5 mM MgCl 2 , 120 mM KCl, 4610 5 c.p.m. of a-32 P-labelled RNA probe, 20 mg of cell extract, 5 mg of heparin, 0.5 mg of tRNA, 7.5 mM creatine phosphate and 1 mM ATP. After incubation at 308C for 10 min, the samples were placed on ice and irradiated with a 254-nm wavelength light (Stratalinker 2400, Stratagene) for 10 min at a distance of 4 cm from the UV source. After cross-linking, the unbound RNA was digested with 20 mg of RNase A for 15 min at 378C. The samples were heated at 1008C for 3 min in 16s.d.s. sample buer, and subjected to s.d.s.-polyacrylamide gel electrophoresis and autoradiography.
